{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:13:39Z","timestamp":1791216819246,"version":"4.1.0"},"reference-count":12,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cephalalgia"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In this study, we aimed to evaluate the differing global access to acute and preventive medications for migraine and tension-type headache.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A custom-built questionnaire created by members of the International Headache Society Juniors Group was sent to International Headache Society members worldwide, including a list of acute and preventive treatments for migraine and tension-type headache. This list was based on evidence-based medicine guidelines. For each treatment, participants were asked about availability, type of reimbursement and variability of access within their country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-four members completed the questionnaire providing data for 84 countries. The majority were neurologists (88%) and worked at an academic\/university hospital (62%). Of participants, 36% were located in high-income economy countries and 13% were located in low-income economies. Common preventive treatments such as propranolol and topiramate were available in most countries (respectively in 99% and 92% of responding countries). Sumatriptan was available in most countries (95%), whereas other triptan availability was lower. Novel migraine treatments such as rimegepant and erenumab were only available in 14% and 46% of the assessed countries, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Availability of headache medications, ranging from simple analgesics to novel therapies migraine-specific drugs, varied greatly across the world. Actions are needed to improve effective drug availability in many countries to ensure an adequate management of people living with headache.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03331024241297688","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T03:38:17Z","timestamp":1731901097000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":33,"title":["Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society"],"prefix":"10.1177","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1933-4049","authenticated-orcid":false,"given":"Francesca","family":"Puledda","sequence":"first","affiliation":[{"name":"Headache Group, Wolfson SPaRC, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-762X","authenticated-orcid":false,"given":"Irene","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-0432","authenticated-orcid":false,"given":"Roberta","family":"Messina","sequence":"additional","affiliation":[{"name":"Neuroimaging Research Unit and Neurology Unit, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3132-1064","authenticated-orcid":false,"given":"David","family":"Garcia-Azorin","sequence":"additional","affiliation":[{"name":"Headache Unit, Department of Neurology, Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-4491","authenticated-orcid":false,"given":"Marcio Nattan","family":"Portes Souza","sequence":"additional","affiliation":[{"name":"Neurology Department, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-9665","authenticated-orcid":false,"given":"Mohammad Al-Mahdi","family":"Al-Karagholi","sequence":"additional","affiliation":[{"name":"Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-1499","authenticated-orcid":false,"given":"Olivia","family":"Begasse de Dhaem","sequence":"additional","affiliation":[{"name":"Hartford HealthCare, University of Connecticut, Westport, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-2113","authenticated-orcid":false,"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"Headache Science & Neurorehabilitation Center, IRCCS C. Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-1506","authenticated-orcid":false,"given":"Arne","family":"May","sequence":"additional","affiliation":[{"name":"Dept. of Systems Neuroscience, University Clinic Hamburg Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"bibr1-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"bibr2-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32160-7"},{"key":"bibr3-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01699-7"},{"key":"bibr4-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00328-4"},{"key":"bibr5-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231159366"},{"key":"bibr6-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231151419"},{"key":"bibr7-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241252666"},{"key":"bibr8-03331024241297688","unstructured":"The World Bank. World Bank Country and Lending Groups, https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. (2023, accessed 28 November 2023)."},{"key":"bibr9-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2023.100466"},{"key":"bibr10-03331024241297688","unstructured":"World Health Organization. World Health Organization Model List of Essential Medicines 2023, https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02. (2023, accessed 1 October 2023)."},{"key":"bibr11-03331024241297688","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.222448"},{"key":"bibr12-03331024241297688","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120645"}],"container-title":["Cephalalgia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024241297688","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03331024241297688","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03331024241297688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:46:07Z","timestamp":1777387567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03331024241297688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/03331024241297688"],"URL":"https:\/\/doi.org\/10.1177\/03331024241297688","relation":{},"ISSN":["0333-1024","1468-2982"],"issn-type":[{"value":"0333-1024","type":"print"},{"value":"1468-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"article-number":"03331024241297688"}}